Correlation Between GlaxoSmithKline PLC and Baird Midcap
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Baird Midcap at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Baird Midcap into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Baird Midcap Fund, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Baird Midcap and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Baird Midcap. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Baird Midcap.
Diversification Opportunities for GlaxoSmithKline PLC and Baird Midcap
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Baird is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Baird Midcap Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Baird Midcap and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Baird Midcap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Baird Midcap has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Baird Midcap go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Baird Midcap
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 2.25 times less return on investment than Baird Midcap. In addition to that, GlaxoSmithKline PLC is 1.25 times more volatile than Baird Midcap Fund. It trades about 0.01 of its total potential returns per unit of risk. Baird Midcap Fund is currently generating about 0.03 per unit of volatility. If you would invest 2,035 in Baird Midcap Fund on August 25, 2024 and sell it today you would earn a total of 328.00 from holding Baird Midcap Fund or generate 16.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Baird Midcap Fund
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Baird Midcap |
GlaxoSmithKline PLC and Baird Midcap Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Baird Midcap
The main advantage of trading using opposite GlaxoSmithKline PLC and Baird Midcap positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Baird Midcap can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baird Midcap will offset losses from the drop in Baird Midcap's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Baird Midcap vs. World Energy Fund | Baird Midcap vs. Hennessy Bp Energy | Baird Midcap vs. Icon Natural Resources | Baird Midcap vs. Alpsalerian Energy Infrastructure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |